The cost of Humalog can vary significantly depending on factors such as insurance coverage, pharmacy, and whether it is a brand-name or generic version.
What influences the price of Humalog?
The list price for Humalog (insulin lispro injection) can be high, but the actual out-of-pocket cost for patients is often reduced by insurance plans, patient assistance programs, and the availability of generic alternatives. For instance, the list price for a 10-mL vial of Humalog KwikPen 100 units/mL can be around $260, and a 5-pack of 3-mL cartridges can cost approximately $300 [1]. However, without insurance, these costs can be substantial.
When can I find cheaper alternatives to Humalog?
Generic versions of insulin lispro have become available, which can offer a lower-cost option. For example, Eli Lilly and Company, the manufacturer of Humalog, also produces its own generic version, often referred to as "insulin lispro injection" [2]. These generics typically enter the market after the patent protection for the brand-name drug expires. DrugPatentWatch.com tracks these patent expiries and generic entry timelines [1].
Are there programs to help with Humalog costs?
Manufacturer-sponsored discount cards and patient assistance programs can significantly lower the cost for eligible individuals. For example, Eli Lilly offers a Humalog Savings Card that can reduce out-of-pocket costs for commercially insured patients [3]. Programs like these aim to make the medication more accessible to those who might otherwise struggle with its price.
What do people pay for Humalog with insurance?
With insurance, the copay for Humalog can range from a few dollars to over $100 per prescription, depending on the specific insurance plan's formulary and the patient's deductible [1]. Many plans have tiered pricing, where generics are placed on lower tiers with lower copays than the brand-name Humalog.
How does the cost of Humalog compare to other insulins?
The cost of insulin is a widely discussed issue, with brand-name insulins like Humalog often being more expensive than their generic counterparts or other insulin formulations. The development of biosimilars for other insulin products has also introduced more competition and potentially lower prices in the broader insulin market [2].
What is the patent status of Humalog?
Humalog, like other prescription drugs, is protected by patents that grant the manufacturer exclusive marketing rights for a certain period. Once these patents expire, generic manufacturers can seek approval to produce and sell their own versions of the drug, which usually leads to a decrease in price [1]. Information on specific patent expiry dates for Humalog and its related formulations is available through resources tracking pharmaceutical patents.
*
**Sources:
[1] DrugPatentWatch.com
[2] Eli Lilly and Company
[3] Eli Lilly and Company Patient Assistance Programs